» Articles » PMID: 28429735

Phylogenetic Analysis of Metastatic Progression in Breast Cancer Using Somatic Mutations and Copy Number Aberrations

Abstract

Several studies using genome-wide molecular techniques have reported various degrees of genetic heterogeneity between primary tumours and their distant metastases. However, it has been difficult to discern patterns of dissemination owing to the limited number of patients and available metastases. Here, we use phylogenetic techniques on data generated using whole-exome sequencing and copy number profiling of primary and multiple-matched metastatic tumours from ten autopsied patients to infer the evolutionary history of breast cancer progression. We observed two modes of disease progression. In some patients, all distant metastases cluster on a branch separate from their primary lesion. Clonal frequency analyses of somatic mutations show that the metastases have a monoclonal origin and descend from a common 'metastatic precursor'. Alternatively, multiple metastatic lesions are seeded from different clones present within the primary tumour. We further show that a metastasis can be horizontally cross-seeded. These findings provide insights into breast cancer dissemination.

Citing Articles

Molecular Underpinnings of Brain Metastases.

Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y Int J Mol Sci. 2025; 26(5).

PMID: 40076927 PMC: 11900073. DOI: 10.3390/ijms26052307.


Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.

Leung M, Swanton C, McGranahan N Nat Rev Genet. 2025; .

PMID: 40065153 DOI: 10.1038/s41576-025-00825-2.


Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X Signal Transduct Target Ther. 2025; 10(1):57.

PMID: 39979279 PMC: 11842613. DOI: 10.1038/s41392-025-02148-4.


SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis.

Tang C, Peng S, Chen Y, Cheng B, Li S, Zhou J MedComm (2020). 2025; 6(2):e70082.

PMID: 39949984 PMC: 11822462. DOI: 10.1002/mco2.70082.


Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.

Huebner H, Wimberger P, Laakmann E, Ruckhaberle E, Ruebner M, Lehle S Precis Clin Med. 2025; 8(1):pbae034.

PMID: 39839709 PMC: 11748133. DOI: 10.1093/pcmedi/pbae034.


References
1.
Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

2.
Carter S, Cibulskis K, Helman E, McKenna A, Shen H, Zack T . Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012; 30(5):413-21. PMC: 4383288. DOI: 10.1038/nbt.2203. View

3.
Toy W, Shen Y, Won H, Green B, Sakr R, Will M . ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013; 45(12):1439-45. PMC: 3903423. DOI: 10.1038/ng.2822. View

4.
Babiera G, Rao R, Feng L, Meric-Bernstam F, Kuerer H, Singletary S . Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006; 13(6):776-82. DOI: 10.1245/ASO.2006.03.033. View

5.
Hong M, Macintyre G, Wedge D, Van Loo P, Patel K, Lunke S . Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun. 2015; 6:6605. PMC: 4396364. DOI: 10.1038/ncomms7605. View